ICU Medical Inc., a supplier of infusion therapy-related medical equipment, reported fourth quarter revenue and profit that ...

Raymond James upgraded ICU Medical (ICUI) to Strong Buy from Outperform with a price target of $97, down from $205. The firm believes the ...

Raymond James added ICU Medical (ICUI) to the firm’s Analyst Current Favorites list. The list contains the current favorite stock ideas from ...

The two-year program will offer advanced training for doctors who have already completed a three-year residency in internal ...

Q4 2024 Earnings Call Transcript February 27, 2025 ICU Medical, Inc. beats earnings expectations. Reported EPS is $2.11, expectations were $1.48. Operator: Good day. And welcome to the ICU Medical, ...

SAN CLEMENTE, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company ...

ICU Medical has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.97, indicating that its share price is 97% more ...

Shareholders might have noticed that ICU Medical, Inc. (NASDAQ:ICUI) filed its annual result this time last week. The early response was not positive, with shares down 7.0% to US$146 in the past week.

Medical device company ICU Medical (NASDAQ:ICUI) will be reporting results tomorrow after market close. Here’s what you need to know. ICU Medical beat analysts’ revenue expectations by 1% last ...

Medical device company ICU Medical (NASDAQ:ICUI) reported Q4 CY2024 results , with sales up 7.1% year on year to $629.8 million. Its non-GAAP profit of $2.11 per share was 42.4% above analysts’ ...

Good day. And welcome to the ICU Medical, Inc. Fourth Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode. After today’s presentation, there will be an ...